[ad_1]
A new treatment to eradicate malaria in Côte d'Ivoire was presented by the Korean laboratory Shin Poong Pharm and his partner Tedis Promo in Abidjan.
This is a new antimalarial called "Pyramax" presented to health professionals and populations in the presence of the Ambassador of the Republic of South Korea in Côte d'Ivoire, Rhee Yong Il. [19659003] Arthemsinine-based combination therapy (ACT), Pyramax is a curative treatment for uncomplicated Plasmodium falciparum and Plasmodium vivax malaria that is administered once a day for three days, promoters say. They added that this antimalarial has formulations suitable for both adults and children (in the form of tablets and granules).
Welcoming the launch of this drug on the Ivorian pharmaceutical market, the professor of infectious and tropical diseases, Emmanuel Bissagnene indicated that "the fight against malaria is in good progress."
In turn, the merits of this antimalarial, Mr. René Cazetien of the laboratory Shin Poong Pharm, claimed that Pyramax "was approved by the European agency and was approved by the World Health Organization (in 2014 for tablets and 2017 for granules)."
Philomene Yai (Stg)
[ad_2]
Source link
